rgdfk peptide Peptide - peptide-t peptide The RGDfK Peptide: A Powerful Tool in Biomedical Research and Therapeutics

rgdfk-peptide The RGDfK peptide, also known as cyclo(Arg-Gly-Asp-D-Phe-Lys), is a synthetic cyclic peptide that has garnered significant attention in biomedical research due to its specific binding affinity for integrins, particularly the αvβ3 integrin. This peptide plays a crucial role in cell adhesion, proliferation, and migration, making it a promising candidate for various therapeutic applications, especially in the field of oncology and tissue engineering.

Understanding the RGDfK Peptide: Structure and Function

The RGDfK peptide is a pentapeptide that incorporates the arginine-glycine-aspartic acid (RGD) motif, a sequence known to interact with a wide range of integrinsCyclicRGDFK peptide. Storage. Store lyophilized at -20ºC, keep desiccated. In lyophilized form, the chemical is stable for 36 months. In solution, store at .... The "fK" portion signifies the presence of D-phenylalanine and Lysine, which contribute to the peptide's cyclic structure and enhanced stability. This cyclic nature, achieved through Fmoc-based solid-phase peptide synthesis and subsequent cyclization, makes the RGDfK peptide more resistant to enzymatic degradation and improves its affinity for target receptors compared to linear RGD peptides.

The primary mechanism of action for the RGDfK peptide lies in its ability to act as a potent and selective αvβ3 integrin inhibitorThe cyclicpeptidec(RGDfK) was built on solid support by standard Fmoc-based solid-phasepeptidesynthesis [28, 29] and modified with TCO in solution after .... Integrins are transmembrane receptors that mediate cell-cell and cell-extracellular matrix interactions. The αvβ3 integrin is highly expressed on endothelial cells of neovascular blood vessels and is upregulated in various pathological conditions, including cancer, where it plays a critical role in tumor angiogenesis and metastasis. By binding to αvβ3 integrins, the RGDfK peptide can effectively block the signaling pathways associated with these receptors, thereby inhibiting tumor growth and the formation of new blood vessels that feed tumors. Studies have shown that the RGDfK peptide has an IC50 of 0.94 nM for αvβ3 integrins, highlighting its remarkable potency.

Applications in Cancer Targeting and Therapy

The specific targeting of αvβ3 integrins makes the RGDfK peptide an attractive agent for cancer therapyc(RGDfK) | C27H41N9O7 | CID 22134127 - PubChem - NIH. Its ability to selectively bind to tumor vasculature allows for targeted drug delivery, minimizing damage to healthy tissues.Biological Activity for Cyclo(-RGDfK). Cyclo(-RGDfK) is a cyclicpeptide, potent integrin inhibitor (IC50 values are 2.3 and 55 nM for αvβ3 and αvβ6, ... This principle is explored in various research avenues:

* Tumor Imaging: RGDfK peptide can be labeled with radioisotopes (ePurpose: The purpose of this study was to demonstrate the valence of cyclic RGDpeptides, P-RGD (PEG4-c(RGDfK): PEG4 = 15-amino-4,710,13-tetraoxapentadecanoic ....g., 125I, 99mTc) or fluorescent markers to facilitate molecular imaging of tumors. These labeled peptides can specifically bind to receptors on neovascular blood vessels of human cancers, enabling early detection and monitoring of treatment responseIt was found to bind specifically and with high affinity to αvβ3 receptors on neovascular blood vessel sections of different major human cancers.. For instance, 111In-labeled cyclic RGD peptides have been evaluated for their diagnostic potential.

* Drug Delivery Systems: The RGDfK peptide can be conjugated to various therapeutic agents, nanoparticles, or polymeric carriers to enhance their delivery to tumor sites. For example, RGDfK peptide modified alginate scaffolds are being investigated for cell scaffolding and drug delivery. Similarly, self-assembled nanoparticles based on the c(RGDfk) peptide have been developed for tumor-targeted drug delivery. Cyclic RGDfK peptide functionalized polymeric nanocarriers are also an area of active research.

* Direct Therapeutic Effects: The direct inhibitory effect of the RGDfK peptide on αvβ3 integrins can disrupt tumor angiogenesis and metastasisThe relationship between the cyclic-RGDfK ligand and .... Research into cancer treatment using peptides often features RGD peptides due to their inherent anti-angiogenic properties.c(RGDfK) | C27H41N9O7 | CID 22134127 - PubChem - NIH

Beyond Cancer: Other Biomedical Applications

The utility of the RGDfK peptide extends beyond cancer therapy:

* Tissue Engineering: The RGDfK peptide can be incorporated into biomaterials to improve cellular adhesion and proliferation. Cyclo(RGDfK) peptide functionalized spider silk cell scaffolds, for instance, aim to enhance cellular interaction with the biomaterial, promoting tissue regeneration. Cyclo(-RGDfK) has also been shown to improve human pluripotent stem cell (hPSC) adhesion and proliferation on synthetic surfaces, making it valuable for stem cell research and regenerative medicine.US20030125243A1 - Synthesis of cyclic peptides

* Wound Healing: By promoting cell adhesion and migration, the RGDfK peptide can potentially accelerate wound healing processes.

* Cardiovascular Research: Given the role of integrins in cardiovascular diseases, RGDfK peptide derivatives are being explored for their potential in treating conditions like atherosclerosis作者：H Kulhari·2016·被引用次数：55—RGDpeptidesare well-known to bind preferentially to the αvβ3 integrin. In this context, targeting tumor cells or tumor vasculature by RGD-based strategies is ....

Synthesis and Modifications

The synthesis of the RGDfK peptide typically involves standard Fmoc-based solid-phase peptide synthesis followed by cyclization.作者：D Harvey·2020·被引用次数：12—A common approach to improve cellular adhesion is to decorate the biomaterial with functional ligands, such aspeptidebased ECM mimics. One ... Various modifications can be introduced to enhance its properties, such as:

* Multimerization: Creating dimeric or tetrameric forms of the RGDfK peptide, such as DOTA-conjugated multivalent cyclic-RGD peptide dendrimers, can increase binding avidity and therapeutic efficacy. E(c(RGDfK))2 is an example of such a multivalent construct with enhanced tumor targeting.The relationship between the cyclic-RGDfK ligand and ...

* Conjugation: The RGDfK peptide can be conjugated to other molecules, including small molecules, fluorophores, radiolabels, and other peptide sequences, to create sophisticated diagnostic and therapeutic agents.Cyclo(-RGDfK) (8917) by Tocris, Part of Bio-Techne DiagNano™ NOTA-c(RGDfK) Peptide Conjugated CdSSe/ZnS Quantum Dots represent an example of such a conjugate.c(RGDfK) is a cyclicpeptiderenowned for its role in cell adhesion and receptor binding studies, offering valuable insights in biochemical research.

* Labeling: For imaging purposes, the RGDfK peptide can be labeled with various isotopes, such as 99mTc using methods like [99mTc][Tc(N)PNP]-tagging of the small RGDfK peptide.

Challenges and Future Directions

Despite its promising applications, challenges remain in the clinical translation of RGDfK peptide-based therapies. These include optimizing delivery, ensuring stability in vivo, and overcoming potential immunogenicityCyclo(-RGDfK) (8917) by Tocris, Part of Bio-Techne. Ongoing research focuses on developing novel delivery strategies, such as cyclic RGDfK peptide functionalized polymeric nanocarriers, and exploring alternative modifications to improve the pharmacokinetic and pharmacodynamic profiles of these peptides.

In conclusion, the RGDfK peptide stands as a significant advancement in peptide-based therapeutics and diagnostics. Its remarkable specificity for αvβ3 integrins and its versatility in various biomedical applications underscore its potential to revolutionize the treatment of cancer and other diseases. Continued research and development in this area promise to unlock the full therapeutic potential of this powerful peptide.Cyclo(RGDfK). Write a review to earn BioPoints. The cyclic pentapeptide cyclo ...PeptideServices;PeptideOverview ·PeptideManufacture · CustomPeptide...